Hip migration percentage in children with cerebral palsy treated with botulinum toxin type A

Archives of Physical Medicine and Rehabilitation

Volumn 86, Issue 3, 2005, Pages 431-435

  Pidcock, Frank S ^a,d   Fish, David E ^b   Johnson Greene, Doug ^a   Borras, Isabel ^c   McGready, John ^a   Silberstein, Charles E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SINAI HOSPITAL OF BALTIMORE   (United States)

^d KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Botulinum toxin type A; Cerebral palsy; Hip; Rehabilitation

Indexed keywords

BOTULINUM TOXIN A;

AGE DISTRIBUTION; CEREBRAL PALSY; CLINICAL TRIAL; CORRELATION ANALYSIS; HIP; HUMAN; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; SPASTICITY;

EID: 14744276683     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2004.03.034     Document Type: Article

References (17)

1. F. Miller, M.R. Bagg Age and migration percentage as risk factors for progression in spastic hip disease Dev Med Child Neurol 37 1995 449 455
2. J.T. Smith, P.M. Stevens Combined adductor transfer, iliopsoas release, and proximal hamstring release in cerebral palsy J Pediatr Orthop 9 1989 1 5
3. M.M. Hoffer Management of hip in cerebral palsy J Bone Joint Surg Am 68 1986 629 631
4. R.N. Boyd, F. Dobson, J. Parrott The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function a randomized controlled trial Eur J Neurol 8 Suppl 5 2001 109 119
5. D. Scrutton, G. Baird, N. Smeeton Hip dysplasia in bilateral cerebral palsy incidence and natural history in children aged 18 months to 5 years Dev Med Child Neurol 43 2001 586 600
6. J. Reimers The stability of the hip in children. A radiological study of the results of muscle surgery in cerebral palsy Acta Orthop Scand 184 Suppl 1980 1 100
7. V. Kalen, E.E. Bleck Prevention of spastic paralytic dislocation of the hip Dev Med Child Neurol 27 1985 17 24
8. N.H. Harris, G.C. Lloyd-Roberts, R. Gallien Acetabular development in congenital dislocation of the hip with special reference to the indications for acetabuloplasty and pelvic or femoral realignment osteotomy J Bone Joint Surg Br 57 1975 46 52
9. F. Heinen, M. Linder, V. Mall, J. Kirschner, R. Korinthenberg Adductor spasticity in children with cerebral palsy and treatment with botulinum toxin A the parent's view of functional outcome Eur J Neurol 6 Suppl 4 1999 47 57
10. T. Poutney, E. Green, P. Gard, A. Many, R. Nelham Retrospective analysis of hip migration in cerebral palsy [abstract] Dev Med Child Neurol 42 Suppl 85 2001 10
11. A.P. Cosgrove, I.S. Corry, H.K. Graham Botulinum toxin in the management of the lower limb in cerebral palsy Dev Med Child Neurol 36 1994 386 396
12. B. Singh Use of botulinum toxin for adductor spasticity in cerebral palsy [abstract] Ann Neurol 36 1994 513
13. P.H. Cooke, W.G. Cole, R.P. Carey Dislocation of the hip in cerebral palsy. Natural history and predictability J Bone Joint Surg Br 71 1989 441 446
14. A. Lespargot, E. Renaudin, N. Khouri, M. Robert Extensibility of hip adductors in children with cerebral palsy Dev Med Child Neurol 36 1994 980 988
15. M.R. Bagg, J. Farber, F. Miller Long-term follow-up of hip subluxation in cerebral palsy patients J Pediatr Orthop 13 1993 32 36
16. M.S. Cornell, N.C. Hatrick, R. Boyd, G. Baird, J.D. Spencer The hip in children with cerebral palsy predicting the outcome of soft tissue surgery Clin Orthop 340 1997 165 171 Jul
17. R. Boyd, H.K. Graham, G. Nattrass Botulinum toxin A (BTX-A) combined with hip bracing delays the need for surgery in children with bilateral cerebral palsy a randomized clinical trial and survivorship analysis [abstract] Dev Med Child Neurol 45 Suppl 96 2003 10